A Phase II Study of Oral Enzastaurin in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane-Containing Regimen

Manuscripts/Articles:

• IE Krop, KD Miller, RT Zon, S Isakoff, CJ Schneider, M Yu, C Johnson, LG Vaughn, OO Shonukan, GW Sledge Jr. A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane-containing regimen: HOG BRE05–97. DOI: 10.1200/jco.2008.26.15_suppl.1004 Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008) 1004-1004. See abstract.